| ADCC | antibody-dependent cellular cytotoxicity |
| ADCP | antibody-dependent cellular phagocytosis |
| Ang-2 | angiopoietin-2 |
| ART-Ig | asymmetric reengineering technology-immunoglobulin |
| BiTE | bispecific T-cell engager |
| C1q | complement component 1q |
| CD | cluster of differentiation |
| CDC | complement-dependent cytotoxicity |
| CDR | complementarity-determining region |
| CH | constant region of heavy chain |
| CHO | Chinese hamster ovarian |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein-4 |
| Fab | fragment antigen binding |
| Fc | fragment crystallizable |
| Fcγ | fragment crystallizable gamma |
| FcRn | neonatal Fc receptor |
| FcγR | Fc gamma receptor |
| FIXa | activated coagulation factor IXa |
| FUT | fucosyltransferase |
| FVIII | coagulation factor VIII |
| FX | coagulation factor X |
| FXa | activated coagulation factor X |
| GlcNAc | N-acetylglucosamine |
| GnTIII | N-acetylglucosaminyltransferase III |
| HAMA | human anti-mouse antibody |
| HER2 | human epidermal growth factor receptor-2 |
| HIV | human immunodeficiency virus |
| IgG | immunoglobulin G |
| IL | interleukin |
| ITAM | tyrosine-based activation motif |
| ITIM | immunoreceptor tyrosine-based inhibitory motif |
| IVIg | intravenous immunoglobulin G |
| κ | kappa light chain |
| kDa | kilodalton (a unit of molecular weight) |
| KiH | “knob-into-holes” design |
| mAbs | monoclonal antibodies |
| MAC | membrane attack complex |
| MHC | major histocompatibility complex 4 |
| NET | neutrophil extracellular trap |
| NK cells | natural killer cells |
| PD-1 | programmed cell death protein-1 |
| PD-L1 | programmed cell death ligand 1 |
| scFv | single-chain variable fragment |
| sdAb | single-domain antibody |
| SEED | strand-exchange engineered domain |
| TNFα | tumor necrosis factor-alpha |
| VEGF | vascular endothelial growth factor |
| VH | variable region of heavy chain |